BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 30146112)

  • 1. Six-year survival of patients with unsuspected uterine malignancy after laparoscopic versus laparotomic myomectomy: An 11-year national retrospective cohort study.
    Yuk JS; Lee JH
    Gynecol Oncol; 2018 Oct; 151(1):91-95. PubMed ID: 30146112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Survival Outcomes in Women with Unsuspected Uterine Malignancy Diagnosed After Laparotomic Versus Laparoscopic Myomectomy: A National, Population-Based Study.
    Yuk JS; Ji HY; Shin JY; Kim LY; Kim SH; Lee JH
    Ann Surg Oncol; 2016 Apr; 23(4):1287-93. PubMed ID: 26577118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seven-year survival analysis in women with unsuspected uterine malignancy after laparotomic versus laparoscopic hysterectomy: A national claim data retrospective cohort study.
    Yuk JS; Lee JH
    Int J Gynaecol Obstet; 2021 May; 153(2):322-329. PubMed ID: 33448028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of morcellation of uterine leiomyosarcomas in laparoscopic supracervical hysterectomy and laparoscopic myomectomy, a retrospective trial including 4791 women.
    Lieng M; Berner E; Busund B
    J Minim Invasive Gynecol; 2015; 22(3):410-4. PubMed ID: 25460521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The incidence of unexpected uterine malignancy in women undergoing hysteroscopic myomectomy or polypectomy: A national population-based study.
    Yuk JS; Shin JY; Moon HS; Lee JH
    Eur J Obstet Gynecol Reprod Biol; 2018 May; 224():12-16. PubMed ID: 29524609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Undetected Cancer at the Time of Laparoscopic Supracervical Hysterectomy and Laparoscopic Myomectomy: Implications for the Use of Power Morcellation.
    Perkins RB; Handal-Orefice R; Hanchate AD; Lin M; Paasche-Orlow MK
    Womens Health Issues; 2016; 26(1):21-6. PubMed ID: 26701205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Incidence of Unexpected Uterine Malignancy in Women Undergoing Hysterectomy for a Benign Condition: A National Population-Based Study.
    Yuk JS; Kim LY; Kim SH; Lee JH
    Ann Surg Oncol; 2016 Nov; 23(12):4029-4034. PubMed ID: 27221362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laparoscopic Myomectomy: A Single-center Retrospective Review of 514 Patients.
    Bean EM; Cutner A; Holland T; Vashisht A; Jurkovic D; Saridogan E
    J Minim Invasive Gynecol; 2017; 24(3):485-493. PubMed ID: 28104498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minilaparotomy Versus Laparoscopic Myomectomy After Cessation of Power Morcellation: Rate of Wound Complications.
    Dubin AK; Wei J; Sullivan S; Udaltsova N; Zaritsky E; Yamamoto MP
    J Minim Invasive Gynecol; 2017; 24(6):946-953. PubMed ID: 28552622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of 30-day Complication Rates between Laparoscopic Myomectomy and Total Laparoscopic Hysterectomy for the Treatment of Uterine Leiomyoma in Women Older Than Age 40.
    Sheyn D; Bretschnieder CE; Mahajan ST; El-Nashar S; Billow M; Ninivaggio CS
    J Minim Invasive Gynecol; 2019; 26(6):1076-1082. PubMed ID: 30385429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does fibroids surgery by endoscopy or laparotomy represent a malignancy threat?
    Mettler L; Abdusattarova K; Alkatout I
    Minerva Ginecol; 2017 Dec; 69(6):517-525. PubMed ID: 28696085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reproductive Outcomes following Use of Barbed Suture during Laparoscopic Myomectomy.
    Pepin K; Dmello M; Sandberg E; Hill-Verrochi C; Maghsoudlou P; Ajao M; Cohen SL; Einarsson JI
    J Minim Invasive Gynecol; 2020; 27(7):1566-1572. PubMed ID: 32109590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of laparoscopic versus minilaparotomic myomectomy on uterine leiomyoma: a meta-analysis.
    Shen Q; Chen M; Wang Y; Zhou Q; Tao X; Zhang W; Zhu X
    J Minim Invasive Gynecol; 2015 Feb; 22(2):177-84. PubMed ID: 25265886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics and management experience of unexpected uterine sarcoma after myomectomy.
    Zhang J; Zhang J; Dai Y; Zhu L; Lang J; Leng J
    Int J Gynaecol Obstet; 2015 Aug; 130(2):195-9. PubMed ID: 26117552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laparoscopic versus abdominal myomectomy: practice patterns and health care use in British Columbia.
    Chen I; Lisonkova S; Joseph KS; Williams C; Yong P; Allaire C
    J Obstet Gynaecol Can; 2014 Sep; 36(9):817-821. PubMed ID: 25222361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disseminated leiomyoma cells can be identified following conventional myomectomy.
    Sandberg EM; van den Haak L; Bosse T; Jansen FW
    BJOG; 2016 Dec; 123(13):2183-2187. PubMed ID: 27533508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advantages of Single-Port Laparoscopic Myomectomy Compared with Conventional Laparoscopic Myomectomy: A Randomized Controlled Study.
    Lee D; Kim SK; Kim K; Lee JR; Suh CS; Kim SH
    J Minim Invasive Gynecol; 2018 Jan; 25(1):124-132. PubMed ID: 28826957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unexpected uterine malignancy in women who have undergone myomectomy.
    Yuk JS; Ji HY; Lee SH; Park YS; Lee JH
    Int J Gynaecol Obstet; 2015 Jun; 129(3):270-1. PubMed ID: 25790796
    [No Abstract]   [Full Text] [Related]  

  • 19. [LAPAROSCOPIC MYOMECTOMY WITH UTERINE ARTERY CLIPPING VERSUS CONVENTIONAL LAPAROSCOPIC MYOMECTOMY].
    Blagovest B; Magunska N; Kovachev E; Ivanov S
    Akush Ginekol (Sofiia); 2015; 54(7):8-10. PubMed ID: 27025101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of uterine sarcoma found incidentally after uterus-preserving surgery for presumed benign disease.
    Lee JY; Kim HS; Nam EJ; Kim SW; Kim S; Kim YT
    BMC Cancer; 2016 Aug; 16(1):675. PubMed ID: 27553655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.